Richard is responsible for commercial marketing efforts for the North America region at LumiraDx. Previously, Richard was a Global Product Manager for bioMérieux/BioFire where he led strategic marketing efforts for the development of multiplex, molecular panels for sepsis, fever of unknown origin in pediatric patients, acute infections in immunocompromised patients, and acute and chronic meningitis/encephalitis. He also set product strategy for point of care systems software and connected solutions for hospital laboratories and decentralized laboratory medicine at the point of care. Prior to working in industry Richard spent 5 years teaching physics, chemistry, and neuroscience at a college preparatory academy. Richard has a bachelor’s degree in psychology from the University of California, San Diego and a master’s in biotechnology from the University of Utah.
Workplace-based testing for SARS-CoV-2, the virus that causes COVID-19, could identify workers with SARS-CoV-2 infection, and thus help prevent or reduce further transmission, but with all these tests coming out, which one should you choose to screen asymptomatic employees, to improve your chance to catch silent spreaders?
ByRichard H. Noel, M.S.
June 28, 2021